Results 71 to 80 of about 98,340 (384)
IMPROVING LAND MANAGEMENT AND PRODUCTIVITY OF CARDAMOM (AMOMUM COMPACTUM) BASED AGROFORESTRY SYSTEM FOR SUPPLY OF ANTI COVID 19 BIOPHARMACEUTICAL RAW MATERIALS [PDF]
Russian Journal of Agricultural and Socio-Economic Sciences, 2022 The aim of the study was to examine the benefit of combination of organic (manure) and an organic fertilizer (NPK) along with the use of biofertilizer to improve cardamon growth and performance as Covid-19 biopharmaceutical raw material.
Reziq M. +3 more
doaj
Process analytical technology (PAT) for biopharmaceuticals [PDF]
, 2011 Process analytical technology (PAT), the regulatory initiative for building in quality to pharmaceutical manufacturing, has a great potential for improving biopharmaceutical production.
Bruggeman +41 more
core +1 more source
Biopharmaceutical applications of nanogold
Saudi Pharmaceutical Journal, 2010 The application of nanogold in biopharmaceutical field is reviewed in this work. The properties of nanogold including nanogold surface Plasmon absorption and nanogold surface Plasmon light scattering are illustrated. The physical, chemical, biosynthesis methods of nanogold preparation are presented.
Ibrahim A. Alsarra +2 more
openaire +2 more sources
Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s) [PDF]
International Journal of Health Policy and Management, 2015 Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS).
Hao Hu, Chao-Chen Chung
doaj +1 more source
Locust bean gum: exploring its potential for biopharmaceutical applications [PDF]
, 2012 Polysaccharides have been finding, in the last decades, very interesting and useful applications in the biomedical and, specifically, in the biopharmaceutical field.
Dionísio, Marita, Grenha, Ana
core +2 more sources
Molecular Oncology, EarlyView.In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
FEBS Open Bio, EarlyView.Berberine–cinnamic acid co‐crystal (BBR‐CA) inhibits the phosphorylation of the phosphatidylinositol 3‐kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, suppressing the transfer of pre‐sterol regulatory element‐binding proteins‐1 (SREBP‐1) from the endoplasmic reticulum to the nucleus. This results in a decrease in the expression level of
Wenheng Gao +7 more
wiley +1 more source
A theoretical framework for estimation of AUCs in complete and incomplete sampling designs. [PDF]
, 2009 Nonclinical in vivo animal studies have to be completed before starting clinical studies of the pharmacokinetic behavior of a drug in humans. The drug exposure in animal studies is often measured by the area under the concentration versus time curve (AUC)
Jaki, Thomas, Wolfsegger, Martin J.
core +1 more source
Adalimumab‐Poloxamer Conjugate for Bio‐Better: Enhanced Stability and Function
Advanced Functional Materials, EarlyView.Antibody‐polymer conjugates, particularly poloxamer conjugates, enhance antibody stability by improving tolerance to physicochemical stress and attenuating proteolysis by proteases. Furthermore, the higher affinity observed with poloxamer conjugation compared to standard PEGylation results in improved therapeutic efficacy in rheumatoid arthritis mouse ...
Jaewon Roh +3 more
wiley +1 more source
Study of firm-level strategic alliances drivers; case study Pharmaceutical industry [PDF]
پژوهشهای مدیریت عمومی, 2015 Commercialization is one of the essential element for development in The biotechnology industry. Nowadays Successful Commercialization is critical for surviving in the competitive markets.
doaj +1 more source